Paper · 21654544
The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms.
Li X and 6 others. Pancreas, 2011. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms. Papers, record 21654544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21654544
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Carrier Proteins | Major topic |
| Immunoglobulin gamma-Chains | Major topic |
| Pancreatic Neoplasms | Major topic |
| Tumor Escape | Major topic |
| Animals | |
| Antibody-Dependent Cell Cytotoxicity | |
| Base Sequence | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| DNA Primers | |
| Female | |
| Humans | |
| Killer Cells, Natural | |
| Mice | |
| Mice, Inbred C57BL | |
| Neoplasm Transplantation | |
| Recombinant Fusion Proteins | |
| Transplantation, Heterologous |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,872,676 | Sex determines the natural killer cell-mediated immunity against pancreatic cancer. | Oncoimmunology | 2026 | https://conductscience.org/library/papers/41872676 | PubMed |
| 41,429,870 | Peptidomics analysis of serum in patients suffered from generalized anxiety disorder. | Sci Rep | 2025 | https://conductscience.org/library/papers/41429870 | PubMed |
| 40,894,284 | Identification of proteomic markers of chronic prostatitis/chronic pelvic pain syndrome treated with melatonin using a tandem mass tag approach. | Curr Urol | 2025 | https://conductscience.org/library/papers/40894284 | PubMed |
| 40,605,071 | Investigating the potential role of EIF2S2 in OSCC progression through comprehensive bioinformatics analysis and experimental validation. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40605071 | PubMed |
| 40,566,633 | Transcriptomic and miRNA Signatures of ChAdOx1 nCoV-19 Vaccine Response Using Machine Learning. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40566633 | PubMed |
| 40,535,807 | Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer. | J Cancer | 2025 | https://conductscience.org/library/papers/40535807 | PubMed |
| 40,427,186 | Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40427186 | PubMed |
| 40,363,705 | Drug Repurposing to Inhibit Oncostatin M in Crohn's Disease. | Molecules | 2025 | https://conductscience.org/library/papers/40363705 | PubMed |
| 38,967,755 | Cancer-Derived Immunoglobulin G and Pancreatic Cancer. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/38967755 | PubMed |
| 38,967,751 | Comparison of Non B-Ig and B-Ig. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/38967751 | PubMed |
1 to 10 of 44
See all 44 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGHG1 | 3,500 | PubTator's text mining | https://conductscience.org/library/genes/3500 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21654544
GET https://conductscience.org/api/papers/v1/21654544/cited_by?page=2